dihexa cancer risk hgf c-met Pancreatic Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib Frontiers | Hepatocyte growth factor

Name: dihexa cancer risk hgf c-met Pancreatic Treatment Targeting the HGF/c-MET Pathway: The MEK Inhibitor Trametinib Frontiers | Hepatocyte growth factor
Brand: buntepalette-gmbh.de
SKU: 5670674777
Price: 23.60 USD
Availability: InStock
Rating: 4.8586 (9 reviews)

SKU: 5670674777

4.9

USD23.60 USD62.60

Pay in 4 interest-free payments of $5.90 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

Live Spec

Frontiers Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure c MET: A Key Target in Cancer Therapy KACTUS Dihexa (PNB 0408) c Met HGFR Activator MedChemExpress Targeting the HGF Met signalling pathway in cancer ScienceDirect

Store: buntepalette-gmbh.de · Domain: buntepalette-gmbh.de

Description

5 People watching this product now

Capsule vs injection which format

Homocysteine is an amino acid

Where a shot description may refer to select natural medicines, a natural medicine blend, a natural medicine formula, a blend of natural medicine, specialized natural medicine, or any other description about natural medicines, each shot contains its own blend of natural medicine that target the symptoms of that particular shot